60 related articles for article (PubMed ID: 8150244)
1. [Controversial attitude to mammography screening in asymptomatic women between 40 and 50 years of age].
Frischbier HJ
Geburtshilfe Frauenheilkd; 1994 Jan; 54(1):1-11. PubMed ID: 8150244
[TBL] [Abstract][Full Text] [Related]
2. Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years.
Miller AB; Baines CJ; To T; Wall C
CMAJ; 1992 Nov; 147(10):1477-88. PubMed ID: 1423088
[TBL] [Abstract][Full Text] [Related]
3. Positive predictive value of screening mammography by age and family history of breast cancer.
Kerlikowske K; Grady D; Barclay J; Sickles EA; Eaton A; Ernster V
JAMA; 1993 Nov; 270(20):2444-50. PubMed ID: 8230621
[TBL] [Abstract][Full Text] [Related]
4. Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years.
Miller AB; Baines CJ; To T; Wall C
CMAJ; 1992 Nov; 147(10):1459-76. PubMed ID: 1423087
[TBL] [Abstract][Full Text] [Related]
5. [40 years breast carcinoma treatment in the Neubrandenburg region.Can an increase in prognostically more favorable stages be detected?].
Rühle H; Grobe N; Balschat S; Ernst KF; Dewitz D; Winkler L
Z Arztl Fortbild Qualitatssich; 1997 Mar; 91(2):135-7. PubMed ID: 9244654
[TBL] [Abstract][Full Text] [Related]
6. Mammography in symptomatic and asymptomatic patients.
Stomper PC; Gelman RS
Hematol Oncol Clin North Am; 1989 Dec; 3(4):611-40. PubMed ID: 2691492
[TBL] [Abstract][Full Text] [Related]
7. Screening mammography: value in women 35-39 years old.
Liberman L; Dershaw DD; Deutch BM; Thaler HT; Lippin BS
AJR Am J Roentgenol; 1993 Jul; 161(1):53-6. PubMed ID: 8517320
[TBL] [Abstract][Full Text] [Related]
8. The detection and diagnosis of early, occult and minimal breast cancer.
Hickey RC; Gallager HS; Dodd GD; Samuels BI; Paulus DD; Moore DL
Adv Surg; 1976; 10():287-312. PubMed ID: 185891
[TBL] [Abstract][Full Text] [Related]
9. Interval breast cancers in the Screening Mammography Program of British Columbia: analysis and classification.
Burhenne HJ; Burhenne LW; Goldberg F; Hislop TG; Worth AJ; Rebbeck PM; Kan L
AJR Am J Roentgenol; 1994 May; 162(5):1067-71; discussion 1072-5. PubMed ID: 8165983
[TBL] [Abstract][Full Text] [Related]
10. [Mammography screening].
Schulz-Wendtland R; Becker N; Bock K; Anders K; Bautz W
Radiologe; 2007 Apr; 47(4):359-69; quiz 370. PubMed ID: 17375277
[TBL] [Abstract][Full Text] [Related]
11. [Contributions of the epidemiological cancer registries to the evaluation of mammography screening in Germany].
Urbschat I; Kieschke J; Schlanstedt-Jahn U; von Gehlen S; Thiel A; Jensch P
Gesundheitswesen; 2005 Jul; 67(7):448-54. PubMed ID: 16103967
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors of breast neoplasms detected on screening by mammography and physical examination.
Feig SA; Schwartz GF; Nerlinger R; Edeiken J
Radiology; 1979 Dec; 133(3 Pt 1):577-82. PubMed ID: 504635
[TBL] [Abstract][Full Text] [Related]
13. Results of intermediate measures from a population-based, randomized trial of mammographic screening prevalence and detection of breast carcinoma among Asian women: the Singapore Breast Screening Project.
Ng EH; Ng FC; Tan PH; Low SC; Chiang G; Tan KP; Seow A; Emmanuel S; Tan CH; Ho GH; Ng LT; Wilde CC
Cancer; 1998 Apr; 82(8):1521-8. PubMed ID: 9554530
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of self-reported screening mammography and impact on breast cancer mortality in Austria.
Vutuc C; Haidinger G; Waldhoer T
Wien Klin Wochenschr; 1998 Jul; 110(13-14):485-90. PubMed ID: 9746962
[TBL] [Abstract][Full Text] [Related]
15. Mammographically detected, clinically occult ductal carcinoma in situ treated with breast-conserving surgery and definitive breast irradiation.
Solin LJ; McCormick B; Recht A; Haffty BG; Taylor ME; Kuske RR; Bornstein BA; McNeese M; Schultz DJ; Fowble BL; Barrett W; Yeh IT; Kurtz JM; Amalric R; Fourquet A
Cancer J Sci Am; 1996; 2(3):158-65. PubMed ID: 9166516
[TBL] [Abstract][Full Text] [Related]
16. The comparative value of mammographic screening for women 40-49 years old versus women 50-64 years old.
Curpen BN; Sickles EA; Sollitto RA; Ominsky SH; Galvin HB; Frankel SD
AJR Am J Roentgenol; 1995 May; 164(5):1099-103. PubMed ID: 7717212
[TBL] [Abstract][Full Text] [Related]
17. Mammography: a critical evaluation of its role in breast cancer screening, especially in developing countries.
Miller AB
J Public Health Policy; 1989; 10(4):486-98. PubMed ID: 2621252
[TBL] [Abstract][Full Text] [Related]
18. [Value of high resolution sonography in breast cancer screening].
Madjar H; Makowiec U; Mundinger A; Du Bois A; Kommoss F; Schillinger H
Ultraschall Med; 1994 Feb; 15(1):20-3. PubMed ID: 8165458
[TBL] [Abstract][Full Text] [Related]
19. National Institutes of Health Consensus Development Conference Statement: breast cancer screening for women ages 40-49, January 21-23, 1997. National Institutes of Health Consensus Developmental Panel.
J Natl Cancer Inst Monogr; 1997; (22):vii-xviii. PubMed ID: 9709265
[TBL] [Abstract][Full Text] [Related]
20. Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population.
Kerlikowske K; Miglioretti DL; Buist DS; Walker R; Carney PA;
J Natl Cancer Inst; 2007 Sep; 99(17):1335-9. PubMed ID: 17698950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
